”We are in desperate need of financing options”
“We are in desperate need of financing options”, says Bavarian Nordic’s CEO. The CEO of Zealand Pharma believes it is all about picking the winners early on – and that process has already begun. See all the answers from the Medwatch Panel to this week’s question: are Danish biotech companies too small?
An analysis from the global database Biotechgate shows that Danish biotech companies are markedly smaller than in the countries we are usually compared to. This week the Medwatch Panel considers if the small size of the companies is a problem for the industry and what could be done about it.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
.jpg&w=384&q=75){kind=logo}
